Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 10, 2009, Pages 4777-4785

  Nolan, John M ^a   O'Reilly, Philip ^a   Loughman, James ^b   Stack, Jim ^a   Loane, Edward ^a   Connolly, Eithne ^a   Beatty, Stephen ^a  

^a Ireland   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

XANTHOPHYLL; ZEAXANTHIN; ACRYLIC ACID RESIN; VISUAL PIGMENT;

AGED; ARTICLE; BLOOD LEVEL; BLUE LIGHT FILTERING LENS IMPLANT; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CUSTOMIZED HETEROCHROMATIC FLICKER PHOTOMETRY; DOUBLE BLIND PROCEDURE; EQUIPMENT DESIGN; EYE EXAMINATION; FEMALE; HUMAN; HUMAN TISSUE; LENS IMPLANT; MALE; OPTICAL DENSITY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPECTRAL SENSITIVITY; VISUAL ACUITY; FEEDING BEHAVIOR; LENS IMPLANTATION; METABOLISM; OPTICS; OXIDATIVE STRESS; PHACOEMULSIFICATION; PHOTOMETRY; PROSPECTIVE STUDY; RADIATION INJURY; RETINA; RETINA MACULA DEGENERATION;

ACRYLIC RESINS; AGED; DOUBLE-BLIND METHOD; FEMALE; FOOD HABITS; HUMANS; LENS IMPLANTATION, INTRAOCULAR; LENSES, INTRAOCULAR; LUTEIN; MACULAR DEGENERATION; MALE; OPTICS AND PHOTONICS; OXIDATIVE STRESS; PHACOEMULSIFICATION; PHOTOMETRY; PROSPECTIVE STUDIES; RADIATION INJURIES; RETINA; RETINAL PIGMENTS; VISUAL ACUITY; XANTHOPHYLLS;

EID: 70349571742     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3277     Document Type: Article

References (71)

1. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572.
2. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82(11):844-851.
3. Beatty S, Koh HH, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45(2):115-134.
4. Algvere PV, Marshall J, Seregard S. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand. 2006; 84(1):4-15.
5. Dillon J, Zheng L, Merriam JC, Gaillard ER. Transmission of light to the aging human retina: possible implications for age related macular degeneration. Exp Eye Res. 2004;79(6):753-759.
6. Snodderly DM, Auran JD, Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci. 1984;25(6):674-685.
7. Stringham JM, Hammond BR, Wooten BR, Snodderly DM. Compensation for light loss resulting from filtering by macular pigment: relation to the S-cone pathway. Optom Vis Sci. 2006;83(12):887-894.
8. Junghans A, Sies H, Stahl W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys. 2001;391(2):160-164.
9. Trieschmann M, van Kuijk FJ, Alexander R, et al. Macular pigment in the human retina: histological evaluation of localization and distribution. Eye. 2008;22(1):132-137.
10. Liu IY, White L, LaCroix AZ. The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health. 1989;79(6):765-769.
11. Krishnaiah S, Das T, Nirmalan PK, et al. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India. Invest Ophthalmol Vis Sci. 2005;46(12): 4442-4449.
12. Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen NV. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol Scand. 2005;83(4):409-418.
13. Klein R, Klein BE, Wong TY, Tomany SC, Cruickshanks KJ. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol. 2002;120(11):1551-1558.
14. West SK, Rosenthal FS, Bressler NM, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol. 1989;107(6):875-879.
15. Khan JC, Shahid H, Thurlby DA, et al. Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br J Ophthalmol. 2006;90(1):29-32.
16. Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration: an Australian case-control study. Ophthalmology. 1997;104(5):770-776.
17. Tomany SC, Cruickshanks KJ, Klein R, Klein BEK, Knudtson MD. Sunlight and the 10-year incidence of age-related maculopathy: The Beaver Dam Eye Study. Arch Ophthalmol. 2004;122(5):750-757.
18. Cruickshanks KJ, Klein R, Klein BEK. Sunlight and age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol. 1993;111(4):514-518.
19. Hirakawa M, Tanaka M, Tanaka Y, et al. Age-related maculopathy and sunlight exposure evaluated by objective measurement. Br J Ophthalmol. 2008;92(5):630-634.
20. Taylor HR, Munoz B, West S, Bressler NM, Bressler SB, Rosenthal FS. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc. 1990;88:163-173; discussion 173-178.
21. Fletcher AE, Bentham GC, Agnew M, et al. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol. 2008;126(10):1396-1403.
22. Wang JJ, Klein R, Smith W, Klein BEK, Tomany S, Mitchell P. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology. 2003;110(10):1960-1967.
23. Brockmann C, Schulz M, Laube T. Transmittance characteristics of ultraviolet and blue-light-filtering intraocular lenses. J Cataract Refract Surg. 2008;34(7):1161-1166.
24. Gaillard ER, Zheng L, Merriam JC, Dillon J. Age-related changes in the absorption characteristics of the primate lens. Invest Ophthalmol Vis Sci. 2000;41(6):1454-1459.
25. Bockelbrink A, Roll S, Ruether K, Rasch A, Greiner W, Willich SN. Cataract surgery and the development or progression of age-related macular degeneration: a systematic review. Surv Ophthalmol. 2008;53(4):359-367.
26. Roodenburg AJ, Leenen R, van het Hof KH, Weststrate JA, Tijburg LB. Amount of fat in the diet affects bioavailability of lutein esters but not of α-carotene, β-carotene, and vitamin E in humans. Am J Clin Nutr. 2000;71(5):1187-1193.
27. Unlu NZ, Bohn T, Clinton SK, Schwartz SJ. Carotenoid absorption from salad and salsa by humans is enhanced by the addition of avocado or avocado oil. J Nutr. 2005;135(3):431-436.
28. Snodderly DM, Chung HC, Caldarella SM, Johnson EJ. The influence of supplemental lutein and docosahexaenoic acid on their serum levels and on macular pigment. Invest Ophthalmol Vis Sci. 2005;46(5):1766.
29. Wooten BR, Hammond BR, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci. 1999;40(11):2481-2489.
30. Hammond BR Jr, Wooten BR, Smollon B. Assessment of the validity of in vivo methods of measuring human macular pigment optical density. Optom Vis Sci. 2005;82(5):387-404.
31. Hammond BR, Wooten BR, Snodderly DM. Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vision. 1997;14(6):1187-1196.
32. Werner JS, Donnelly SK, Kliegl R. Aging and human macular pigment density: appended with translations from the work of Max Schultze and Ewald Hering. Vision Res. 1987;27:257-268.
33. Hammond BR, Caruso-Avery M. Macular pigment optical density in a southwestern sample. Invest Ophthalmol Vis Sci. 2000;41(6): 1492-1497.
34. Nolan JM, Stringham JM, Beatty S, Snodderly DM. Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci. 2008;49(5):2134-2142.
35. Loane E, Stack J, Beatty S, Nolan JM. Measurement of macular pigment optical density using two different heterochromatic flicker photometers. Curr Eye Res. 2007;32(6):555-564.
36. Tyler CW. Two processes control variations in flicker sensitivity over the life span. J Opt Soc Am A. 1989;6(4):481-490.
37. Falsini B, Fadda A, Iarossi G, et al. Retinal sensitivity to flicker modulation: reduced by early age-related maculopathy. Invest Ophthalmol Vis Sci. 2000;41(6):1498-1506.
38. Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M, Ficek T. Macular pigment measurement by heterochromatic flicker photometry in older subjects: The carotenoids and age-related eye disease study. Invest Ophthalmol Vis Sci. 2004;45(2):531-538.
39. Phipps JA, Dang TM, Vingrys AJ, Guymer RH. Flicker perimetry losses in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45(9):3355-3360.
40. Witmer AN, Vrensen GFJM, Van Noorden CJF, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res. 2003;22(1):1-29.
41. Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology. 1996;103(10):1546-1554.
42. Sparrow JR, Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci. 2001;42(6):1356-1362.
43. Yanagi Y, Inoue Y, Iriyama A, Jang WD. Effects of yellow intraocular lenses on light-induced upregulation of vascular endothelial growth factor. J Cataract Refract Surg. 2006;32(9):1540-1544.
44. Sparrow JR, Miller AS, Zhou J. Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg. 2004;30(4):873-878.
45. Feeneyburns L, Hilderbrand ES, Eldridge S. Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest Ophthalmol Vis Sci. 1984;25(2):195-200.
46. Pierre A, Wittich W, Faubert J, Overbury O. Luminance contrast with clear and yellow-tinted intraocular lenses. J Cataract Refract Surg. 2007;33(7):1248-1252.
47. Mainster MA, Sparrow JR. How much blue light should an IOL transmit? Br J Ophthalmol. 2003;87(12):1523-1529.
48. Cionni RJ, Tsai JH. Color perception with AcrySof natural and AcrySof single-piece intraocular lenses under photopic and mesopic conditions. J Cataract Refract Surg. 2006;32(2):236-242.
49. Mayer S, Wirbelauer C, Pham DT. Functional results after intraocular lens implantation with or without blue light filter: an intraindividual comparison (in German). Klin Monatsbl Augenheilkd. 2006;223(2):142-146.
50. Hayashi K, Hayashi H. Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non-tinted intraocular lenses. Br J Ophthalmol. 2006;90(8):1019-1023.
51. Landers J, Tan TH, Yuen J, Liu H. Comparison of visual function following implantation of Acrysof Natural intraocular lenses with conventional intraocular lenses. Clin Exp Ophthalmol. 2007; 35(2):152-159.
52. Leibovitch I, Lai T, Porter N, Pietris G, Newland H, Selva D. Visual outcomes with the yellow intraocular lens. Acta Ophthalmol Scand. 2006;84(1):95-99.
53. Barisic A, Dekaris I, Gabric N, et al. Blue light filtering intraocular lenses in phacoemulsification cataract surgery. Coll Antropol. 2007;31(suppl 1):57-60.
54. Niwa K, Yoshino Y, Okuyama F, Tokoro T. Effects of tinted intraocular lens on contrast sensitivity. Ophthalmic Physiol Opt. 1996;16(4):297-302.
55. Muftuoglu O, Karel F, Duman R. Effect of a yellow intraocular lens on scotopic vision, glare disability, and blue color perception. J Cataract Refract Surg. 2007;33(4):658-666.
56. Rodriguez-Galietero A, Montes-Mico R, Munoz G, Barran-Diego C. Comparison of contrast sensitivity and color discrimination after clear and yellow intraocular lens implantation. J Cataract Refract Surg. 2005;31(9):1736-1740.
57. Schmidinger G, Menapace R, Pieh S. Intraindividual comparison of color contrast sensitivity in patients with clear and blue-lightfiltering intraocular lenses. J Cataract Refract Surg. 2008;34(5): 769-773.
58. Bhattacharjee H, Bhattacharjee K, Medhi J. Visual performance: comparison of foldable intraocular lenses. J Cataract Refract Surg. 2006;32(3):451-455.
59. Marshall J, Cionni RJ, Davison J, et al. Clinical results of the blue-light filtering AcrySof Natural foldable acrylic intraocular lens. J Cataract Refract Surg. 2005;31(12):2319-2323.
60. Werner JS. Night vision in the elderly: consequences for seeing through a "blue filtering" intraocular lens. Br J Ophthalmol. 2005; 89(11):1518-1521.
61. Schwiegerling J. Blue-light-absorbing lenses and their effect on scotopic vision. J Cataract Refract Surg. 2006;32(1):141-144.
62. Aharonoff GB, Dennis MG, Elshinawy A, Zuckerman JD, Koval KJ. Circumstances of falls causing hip fractures in the elderly. Clin Orthop Relat Res. 1998;(348):10-14.
63. Norton R, Campbell AJ, Lee-Joe T, Robinson E, Butler M. Circumstances of falls resulting in hip fractures among older people. J Am Geriatr Soc. 1997;45(9):1108-1112.
64. Vetter NJ, Lewis PA, Ford D. Can health visitors prevent fractures in elderly people? BMJ. 1992;304(6831):888-890.
65. Mainster MA, Timberlake GT. Why HID headlights bother older drivers. Br J Ophthalmol. 2003;87(1):113-117.
66. Espindle D, Crawford B, Maxwell A, et al. Quality-of-life improvements in cataract patients with bilateral blue light-filtering intraocular lenses: clinical trial. J Cataract Refract Surg. 2005;31(10): 1952-1959.
67. Loane E, Kelliher C, Beatty S, Nolan JM. The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br J Ophthalmol. 2008;92(9):1163-1168.
68. Rozanowska M, Jarvis-Evans J, Korytowski W, Boulton ME, Burke JM, Sarna T. Blue light-induced reactivity of retinal age pigment: in vitro generation of oxygen-reactive species. J Biol Chem. 1995; 270(32):18825-18830.
69. Ciulla TA, Hammond BR Jr, Yung CW, Pratt LM. Macular pigment optical density before and after cataract extraction. Invest Ophthalmol Vis Sci. 2001;42(6):1338-1341.
70. Nolan JM, Stack J, Mellerio J, Godhinio M, O'Donovan O, Beatty S. Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res. 2006; 31(2):199-213.
71. Wenzel AJ, Fuld K, Stringham JM. Light exposure and macular pigment optical density. Invest Ophthalmol Vis Sci. 2003;44(1): 306-309.